Medical Procedure News

RSS

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".

31 Aug 2010

Neurobiological markers of depression can help tailor antidepressant treatment to the brain

Depression is actually defined by specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks, with impairment of psychosocial functioning. These symptoms guide the physician to make a diagnosis and to select antidepressant treatment such as drugs or psychotherapy.

31 Aug 2010

DePuy Orthopaedics sued over faulty hip-implant devices

Hip-implant surgery is commonplace, but a higher than expected number of failures began to surface in patients who had received an implanted device manufactured by a division of J&J. According to company statistics, about one in eight implant patients requires a painful and expensive second procedure called a "revision surgery."

31 Aug 2010

Study evaluates response to psychotherapeutical interventions in anorexia nervosa

This study demonstrates that the distinction between threshold and subthreshold anorexia nervosa does not seem to be of clinical relevance in terms of response to cognitive-behavioral therapy (CBT). Shape concern rather than demographic or general psychopathological features represents the best predictor of outcome for CBT.

31 Aug 2010

ESC/EACTS releases new Myocardial Revascularisation guidelines

Multivessel and left main disease have been long considered as mainstay indications for coronary artery bypass grafting surgery (CABG). This recommendation, however, has been strongly challenged on several occasions. The release of new Myocardial Revascularisation guidelines by ESC and the European Association of Cardio-Thoracic Surgeons (EACTS) at the ESC Congress on Sunday 29 August is likely to shed new light on what has become a controversial topic.

31 Aug 2010

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Bioheart, Inc., The mission of the Cell Therapy Foundation is to improve public health through the support of effective adult stem cell research and education. The Foundation aims to promote basic and applied knowledge, processes and cell therapies.

31 Aug 2010

Study finds cognitive behaviour therapy safe for chronic fatigue syndrome

The aim of this study is to examine the frequency and severity of symptom deterioration during cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS). Patients receiving CBT do not experience more frequent or more severe symptom deterioration than untreated patients. The reported deterioration during CBT seems to reflect the natural variation in symptoms. Thus, CBT is not only a helpful, but also a safe treatment for CFS.

31 Aug 2010

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

The advantages of prescribing angiotensin-converting enzyme (ACE) inhibitors for stable coronary artery disease (CAD) may be increased by targeting the therapy to the patients most likely to benefit.Clinical characteristics alone do not allow a reliable identification of these patients, so a research programme was carried out at Erasmus University Medical Centre in Rotterdam to develop a genetic profiling model that predicts the treatment benefits of ACE inhibitors and optimises the recommended therapy.

31 Aug 2010

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

Results from the LESSON I trial presented today provide preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent. Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) - the principal shortcoming of early generation drug-eluting stents - may be diminished with the newer generation everolimus-eluting stent.

31 Aug 2010

Infants born by early elective C-section likely to have health problems: Study

Medical experts point to a disturbing trend of expectant mothers who are choosing to deliver their babies for non-medical reasons before 39 weeks of pregnancy.

31 Aug 2010

Using clopidogrel, PPIs increases cardiac damage risk: Study

Patients with coronary artery disease undergoing stent implantation are often prescribed the antiplatelet drug, clopidogrel. This drug prevents blood clots, but is known to have a side-effect that can cause stomach bleeding. Consequently, many users are also prescribed a proton pump inhibitor (PPI). Now, however, a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, has shown that simultaneous use of these drugs can increase the risk of cardiac damage.

31 Aug 2010

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

As one of the leading medical centers in the U.S. diagnosing and treating twin-to-twin transfusion syndrome (TTTS), Texas Children's Fetal Center is proud to announce the successful completion of its 200th TTTS laser ablation surgery.

31 Aug 2010

Data suggests BIMA improves coronary artery bypass graft efficiency

Recent trial data indicate that coronary artery bypass graft (CABG) surgery remains the most effective intervention for patients with severe coronary artery disease (CAD).

31 Aug 2010

African-Americans at higher risk of developing stent thrombosis

African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.

31 Aug 2010

Wellspring Cardiovascular and St. Anthony's Houston partner to reduce amputations

WELLSPRING CARDIOVASCULAR and ST. ANTHONY'S HOSPITAL announce a novel partnership in a move to dramatically reduce the number of amputations in the Houston area.

31 Aug 2010

First time use of ExAblate MR Guided Focused Ultrasound System for prostate cancer treatment

Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.

31 Aug 2010

SIR issues position statement to determine safety, effectiveness of interventional M.S. treatment

Recognizing that venous interventions may potentially play an important role in treating some patients who suffer from multiple sclerosis an incurable, disabling disease the Society of Interventional Radiology has issued a position statement indicating its support for high quality clinical research to determine the safety and effectiveness of interventional M.S. treatments.

31 Aug 2010

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Aspirin and thienopyridine antiplatelet therapy (such as clopidogrel) are standard care in the treatment of acute coronary syndrome (ACS) and even in stable coronary artery disease (CAD) after coronary intervention with stent. However, effective antiplatelet agents are needed which do not increase the risk of bleeding.

31 Aug 2010

Antithrombotic therapy increases bleeding risk in CAD patients: Research

Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.

31 Aug 2010

First UK PyroTITAN Humeral Resurfacing Implant performed at BMI - The Alexandra Hospital

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces the implantation of the first PyroTITAN™ Humeral Resurfacing Implant in the United Kingdom. The PyroTITAN was implanted at BMI - The Alexandra Hospital in Cheadle, Cheshire.

31 Aug 2010

Medical Procedure News

CORDIS reports positive results from 10-year follow-up of CYPHER Sirolimus-eluting coronary stent study

Neurobiological markers of depression can help tailor antidepressant treatment to the brain

DePuy Orthopaedics sued over faulty hip-implant devices

Study evaluates response to psychotherapeutical interventions in anorexia nervosa

ESC/EACTS releases new Myocardial Revascularisation guidelines

Bioheart's MyoCell adult stem cell therapy shows effective for heart failure patients: Study

Study finds cognitive behaviour therapy safe for chronic fatigue syndrome

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

LESSON I trial provides evidence of benefits of everolimus-eluting stent over sirolimus-eluting stent

Infants born by early elective C-section likely to have health problems: Study

Using clopidogrel, PPIs increases cardiac damage risk: Study

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

Data suggests BIMA improves coronary artery bypass graft efficiency

African-Americans at higher risk of developing stent thrombosis

Wellspring Cardiovascular and St. Anthony's Houston partner to reduce amputations

First time use of ExAblate MR Guided Focused Ultrasound System for prostate cancer treatment

SIR issues position statement to determine safety, effectiveness of interventional M.S. treatment

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Antithrombotic therapy increases bleeding risk in CAD patients: Research

First UK PyroTITAN Humeral Resurfacing Implant performed at BMI - The Alexandra Hospital

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News